The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Hold" from Brokerages

Key Points

• Beauty Health has an average “Hold” rating among seven analysts: five holds, one sell and one buy. The average 12-month price target is $1.38.
• SKIN shares opened at $0.63, near the lower end of their 12-month range of $0.55 to $1.76, with a market capitalization of approximately $82 million.
• The company matched quarterly EPS expectations at a loss of $0.02 per share, but revenue of $72.11 million fell short of the $74.45 million analyst consensus; analysts expect a full-year loss of $0.16 per share.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has been given an average rating of "Hold" by the seven analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $1.38.

Several brokerages recently weighed in on SKIN. Zacks Research downgraded shares of Beauty Health from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 20th. TD Cowen decreased their target price on shares of Beauty Health from $1.00 to $0.90 and set a "hold" rating for the company in a research report on Wednesday, August 12th. Finally, Weiss Ratings cut Beauty Health from a "sell (d-)" rating to a "sell (e+)" rating in a report on Thursday, July 23rd.

Beauty Health Price Performance

Shares of SKIN opened at $0.63 on Friday. The company has a market cap of $81.99 million, a P/E ratio of -2.86 and a beta of 1.05. The stock has a fifty day moving average price of $0.67 and a 200 day moving average price of $0.76. The company has a debt-to-equity ratio of 4.36, a current ratio of 1.76 and a quick ratio of 1.48. Beauty Health has a 12 month low of $0.55 and a 12 month high of $1.76.

Beauty Health (NASDAQ:SKIN - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.02) earnings per share for the quarter, hitting the consensus estimate of ($0.02). Beauty Health had a negative return on equity of 47.83% and a negative net margin of 9.79%.The firm had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. On average, research analysts forecast that Beauty Health will post -0.16 earnings per share for the current year.

Institutional Trading of Beauty Health

Several hedge funds have recently added to or reduced their stakes in SKIN. Diversified Trust Co bought a new position in shares of Beauty Health in the first quarter worth $25,000. Bank of America Corp DE raised its stake in shares of Beauty Health by 19.2% during the first quarter. Bank of America Corp DE now owns 106,242 shares of the company's stock valued at $95,000 after purchasing an additional 17,088 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in Beauty Health by 29.6% in the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company's stock worth $253,000 after purchasing an additional 64,900 shares during the period. Finally, Capricorn Fund Managers Ltd acquired a new stake in Beauty Health in the first quarter worth about $17,270,000. Institutional investors own 93.26% of the company's stock.

About Beauty Health

Beauty Health NASDAQ: SKIN is a global health and beauty company focused on providing technology-enabled skincare treatments and products. Its portfolio is centered on aesthetic and wellness solutions designed to be delivered through dermatology practices, medical spas, aesthetic clinics and other professional providers.

The company's best-known brand is Hydrafacial, which offers noninvasive facial treatments that combine cleansing, exfoliation, extraction and hydration. BeautyHealth also provides related products and technologies, including professional treatment systems, skincare formulations, consumables and digital tools intended to support providers and enhance the consumer experience.

BeautyHealth became a publicly traded company in 2021 through a business combination with Vesper Healthcare Acquisition Corp.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.